TNFSF9 and neoplasm: It is noteworthy that HDACi treatment did not induce 4-1BBL transcription in breast-derived tumor cells lines, nor did it induce significant 4-1BBL transcription in primary human peripheral blood lymphocytes, suggesting leukemia specific modulation of 4-1BBL by HDACi treatment (BV, data not shown).